Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.
about
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eyeSmall-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression.Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library.Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping.Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds.Safety and toxicity of nanomaterials for ocular drug delivery applications.Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy.Relevance of Lipid-Based Products in the Management of Dry Eye Disease.Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease.Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease.
P2860
Q35094304-4848ACA0-27B7-47D6-8779-4B4A465B6251Q35171132-CC55C6D0-243A-4FFF-8FDA-51B2BCAB72FBQ35973174-2712F116-A569-451E-A852-4A57C173391AQ36656777-79440E24-EBCA-4E24-9458-205D4625E1B8Q38674125-CE16B168-B299-4773-A3A9-859B1815CBC0Q38793489-F6ED39C5-C6DE-47A5-82B9-07662FBA9724Q39386513-0605039B-67AE-445F-9D8F-C6726A2A4DF0Q40573088-87AE1BA2-162C-4A61-BB02-4DCB17872870Q43119649-2C41AF0C-C3A9-4521-9674-7AFE27DD9503Q47645371-14C2FC4E-A64D-4689-82C8-420ACF94CFA8Q51787921-E585286C-29B4-44A5-9ABC-6E455B4FB7ADQ53836361-ECE08B08-DA7E-4CBE-86D0-A021459C914D
P2860
Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Benefits of cetalkonium chlori ...... ical ophthalmic drug delivery.
@en
type
label
Benefits of cetalkonium chlori ...... ical ophthalmic drug delivery.
@en
prefLabel
Benefits of cetalkonium chlori ...... ical ophthalmic drug delivery.
@en
P2093
P2860
P921
P356
P1476
Benefits of cetalkonium chlori ...... ical ophthalmic drug delivery.
@en
P2093
Frédéric Lallemand
Jean-Sébastien Garrigue
Philippe Daull
P2860
P304
P356
10.1111/JPHP.12075
P577
2014-04-01T00:00:00Z